Davion Healthcare Plc (DAVI)

Market Cap	n/a
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	558,417
Open	12.25
IPO Price	n/a
Day's Range	9.52 - 12.30
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DAVI

Davion Healthcare Plc is an Irish Public Limited Company focused exclusively on the development and commercialization of non-invasive home diagnostic tests for the early detection of health anomalies, including cancers. Our products are classified as Class I medical devices and are fully registered with regulatory authorities in the United States (FDA), the European Union (CE mark), and the United Kingdom (UKCA). Our flagship product, BreastCheck, is a non-invasive home test designed to detect temperature anomalies in breast tissue, which may b...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 22, 2026
• Country: Ireland
• Stock Exchange: Nasdaq
• Ticker Symbol: DAVI
• Website: https://www.davionhealthcare.com/

Financial Performance

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 23, 2026

Data Sources Report a data error